Sayan Chakraborty | Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Sayan Chakraborty | Molecular Biology | Best Researcher Award

Assistant Professor of Oncology from Roswell Park Comprehensive Cancer Center, United States

Dr. Sayan Chakraborty is an Assistant Professor of Oncology at Roswell Park Comprehensive Cancer Center, specializing in cancer biology and regenerative medicine. His research focuses on the role of extracellular matrix (ECM) proteins in cancer progression, particularly in liver cancer. With a strong background in microbiology, immunology, and cancer research, he has made significant contributions to understanding tumor microenvironments. Dr. Chakraborty has published extensively in high-impact journals, secured multiple research grants, and holds patents related to cancer diagnostics and therapies. He actively mentors Ph.D. students and postdoctoral researchers while serving on editorial boards of prestigious scientific journals. His work has been recognized through several national and international awards, including the A*STAR Career Development Award and Open Fund Young Investigator Grant. As an invited speaker at international conferences, he continues to shape the field of cancer research through his pioneering work in mechanotransduction and ECM-targeted therapies.

Professional Profile

Education

Dr. Chakraborty completed his Bachelor of Science (B.Sc.) in Zoology with honors from Presidency College, University of Calcutta, in 2006. He then pursued a Master of Science (M.Sc.) in Biochemistry at the University of Calcutta, graduating in 2008. His doctoral studies focused on the entry mechanisms of oncogenic human herpesvirus-8 (HHV-8/KSHV) and their role in Kaposi’s sarcoma development. He earned his Ph.D. from Rosalind Franklin University of Medicine and Sciences, USA, in collaboration with the Institute of Molecular and Cell Biology, Singapore. His postdoctoral training further refined his expertise in microbiology, immunology, and cancer research. With extensive training across renowned institutions in India, the USA, and Singapore, Dr. Chakraborty has built a strong foundation in cancer biology, extracellular matrix research, and mechanotransduction pathways in tumor progression.

Professional Experience

Dr. Chakraborty has held various research and academic positions across multiple prestigious institutions. He began his career as a Research Fellow at the Institute of Molecular and Cell Biology (IMCB), Singapore, in 2012. He was later promoted to Senior Research Fellow and then Research Assistant Professor at the same institute, focusing on cancer research and extracellular matrix dynamics. In 2022, he joined Roswell Park Comprehensive Cancer Center as an Assistant Professor of Oncology, where he is also a member of the Developmental Therapeutics Research Program. Additionally, he plays an active role in graduate education and experimental therapeutics programs. His research contributions extend beyond academia, as he serves as an editorial board member and peer reviewer for high-impact journals. His work in ECM-targeted cancer therapies and mechanotransduction has led to international recognition, positioning him as a key figure in oncology research.

Research Interests

Dr. Chakraborty’s research focuses on the role of extracellular matrix proteins in cancer progression and regenerative medicine. His laboratory investigates how tumor cells interact with ECM components, leading to changes in mechanotransduction pathways that drive oncogenic signaling. A major aspect of his work revolves around Agrin, a key ECM protein that promotes cancer progression through YAP/TAZ signaling and integrin-mediated mechanosensing. His studies explore how ECM-targeted strategies can disrupt tumor growth and angiogenesis, offering new therapeutic approaches for hepatocellular carcinoma and other cancers. Additionally, he is interested in the intersection of ECM biology and tissue regeneration, aiming to develop novel biomaterials for wound healing applications. His long-term research goal is to devise tumor-restraining strategies by targeting ECM components and their interactions with cancer cells, leading to more effective treatment options for patients.

Research Skills

Dr. Chakraborty has expertise in multiple advanced research methodologies, including molecular and cellular biology, cancer signaling, and mechanotransduction analysis. His laboratory specializes in ECM protein characterization, cancer cell migration assays, and 3D tumor modeling. He is proficient in high-resolution imaging techniques, such as confocal and electron microscopy, to analyze ECM-cancer interactions. Additionally, his skills in RNA sequencing, proteomics, and CRISPR-based gene editing allow for comprehensive molecular investigations in oncology. He has experience in preclinical cancer models, including xenograft and organoid systems, to study tumor microenvironments and evaluate potential therapeutics. His ability to integrate mechanobiology with cancer research has led to groundbreaking discoveries in ECM-targeted therapies. Beyond experimental techniques, he is skilled in grant writing, scientific publishing, and mentoring researchers, further contributing to the advancement of oncology research.

Awards and Honors

Dr. Chakraborty has received numerous accolades for his contributions to cancer research. He was awarded the Aparajita Memorial Gold Medallion for securing the first rank in his B.Sc. studies at Presidency College. He also received the CSIR-UGC Merit Scholarship and the University of Calcutta Foreign Scholarship for academic excellence. His doctoral work earned him the Dean’s Award for Outstanding Achievement in Research from Rosalind Franklin University. In Singapore, he was honored with the Early Career Research Award and the Open Fund Young Investigator Research Grant. His A*STAR Career Development Award recognized his pioneering work in ECM-targeted therapies. Recently, he secured the Cancer Center Support Grant at Roswell Park, further advancing his research into ECM and cancer therapeutics. These awards highlight his consistent excellence in research, funding acquisition, and scientific innovation.

Conclusion

Dr. Sayan Chakraborty is a leading researcher in cancer biology, with extensive contributions to understanding the extracellular matrix’s role in tumor progression. His research has led to the identification of ECM-targeted therapeutic strategies, with a particular focus on liver cancer. With a strong academic background, multiple international research experiences, and significant funding successes, he has established himself as a distinguished scientist in oncology. His mentorship, editorial roles, and extensive publication record further reflect his dedication to advancing cancer research. While his work is already making an impact, expanding clinical collaborations and large-scale translational studies could enhance the real-world applications of his findings. Dr. Chakraborty’s pioneering research, coupled with his leadership in the field, makes him a strong candidate for prestigious research awards and continued recognition in cancer biology.

Publications Top Notes

  1. Title: Agrin as a Mechanotransduction Signal Regulating YAP through the Hippo Pathway
    Authors: S. Chakraborty, K. Njah, A. Pobbati, Y.B. Lim, A. Raju, M. Lakshmanan, …
    Year: 2017
    Citations: 225

  2. Title: Kaposi’s sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes
    Authors: V.V. Singh, N. Kerur, V. Bottero, S. Dutta, S. Chakraborty, M.A. Ansari, …
    Year: 2013
    Citations: 175

  3. Title: An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma
    Authors: S. Chakraborty, M. Lakshmanan, H.L.F. Swa, J. Chen, X. Zhang, Y.S. Ong, …
    Year: 2015
    Citations: 155

  4. Title: Kaposi’s sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection
    Authors: S. Chakraborty, M.V. Veettil, V. Bottero, B. Chandran
    Year: 2012
    Citations: 125

  5. Title: Kaposi’s sarcoma associated herpesvirus entry into target cells
    Authors: S. Chakraborty, M. Valiya Veettil, B. Chandran
    Year: 2012
    Citations: 110

  6. Title: Interaction of c-Cbl with Myosin IIA Regulates Bleb Associated Macropinocytosis of Kaposi’s Sarcoma-Associated Herpesvirus
    Authors: M.V. Veettil, S. Sadagopan, N. Kerur, S. Chakraborty, B. Chandran
    Year: 2010
    Citations: 82

  7. Title: Angiogenin functionally interacts with p53 and regulates p53-mediated apoptosis and cell survival
    Authors: S. Sadagopan, M.V. Veettil, S. Chakraborty, N. Sharma-Walia, N. Paudel, …
    Year: 2012
    Citations: 73

  8. Title: Reactive oxygen species are induced by Kaposi’s sarcoma-associated herpesvirus early during primary infection of endothelial cells to promote virus entry
    Authors: V. Bottero, S. Chakraborty, B. Chandran
    Year: 2013
    Citations: 65

  9. Title: EphrinA2 regulates clathrin mediated KSHV endocytosis in fibroblast cells by coordinating integrin-associated signaling and c-Cbl directed polyubiquitination
    Authors: D. Dutta, S. Chakraborty, C. Bandyopadhyay, M. Valiya Veettil, M.A. Ansari, …
    Year: 2013
    Citations: 63

  10. Title: Linking extracellular matrix agrin to the hippo pathway in liver cancer and beyond
    Authors: S. Chakraborty, W. Hong
    Year: 2018
    Citations: 60

  11. Title: c-Cbl-Mediated Selective Virus-Receptor Translocations into Lipid Rafts Regulate Productive Kaposi’s Sarcoma-Associated Herpesvirus Infection in Endothelial Cells
    Authors: S. Chakraborty, M. Valiya Veettil, S. Sadagopan, N. Paudel, B. Chandran
    Year: 2011
    Citations: 54

  12. Title: The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability
    Authors: A.M. Roy, R. Iyer, S. Chakraborty
    Year: 2023
    Citations: 47

Khalid Subhi Ibrahim | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Khalid Subhi Ibrahim | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Followship at University of Zakho, United Kingdom

Dr. Khalid Subhi Ibrahim, an Assistant Professor at the University of Zakho, is a distinguished researcher in biomedical sciences, specializing in diagnostic and molecular microbiology, clinical biochemistry, and microbiome analysis. With a Ph.D. from Glasgow Caledonian University, his work focuses on understanding gut bacterial communities in obesity, Type 2 diabetes, and other health conditions using cutting-edge techniques like next-generation sequencing and bioinformatics tools such as QIIME2 and PICRUSt2. He has led significant collaborations, including projects with the Massachusetts Institute of Technology (MIT) and Kiel University, Germany, and has contributed to global microbiome conservancy efforts. An Editor-in-Chief of SJUOZ and a committee member of MVIF, Dr. Ibrahim’s expertise extends to training scientists, publishing research, and presenting at international conferences. His diverse contributions reflect his commitment to advancing microbiome research and its applications in health and environmental sciences.

Professional Profile

Education

Dr. Khalid Subhi Ibrahim holds a Ph.D. in Life Sciences from Glasgow Caledonian University, UK (2013-2017), where his research focused on “Biochemical Interactions Between the Gut Microbiome and Host in Obesity/Type 2 Diabetes.” He also completed an MSc in Veterinary Pathology specializing in fish diseases at the University of Duhok, Kurdistan Region, Iraq (2006-2008), presenting a thesis on pathological studies in common carp infected with Aeromonas hydrophila. Dr. Khalid earned his Bachelor of Veterinary Medicine (Medicine and Surgery) from the same institution in 2004. Additionally, he attended a Pre-sessional English Language program at Glasgow University in 2012. Throughout his education, Dr. Khalid developed extensive expertise in microbiology, molecular diagnostics, and bioinformatics. His academic foundation reflects a robust combination of veterinary science, microbiological research, and advanced molecular techniques, forming the basis of his prolific career in microbiome studies and biomedical sciences.

Professional Experience

Dr. Khalid Subhi Ibrahim is an accomplished Assistant Professor with extensive experience in biomedical sciences, specializing in diagnostic and molecular microbiology, clinical biochemistry, and gut microbiome research. He has a strong background in utilizing advanced molecular techniques such as next-generation sequencing, bioinformatics, and 16S rRNA analysis to explore microbiota in various contexts, including obesity, Type 2 diabetes, pollution, and animal health. Dr. Ibrahim has collaborated with prestigious institutions such as Glasgow Caledonian University, Monash University, MIT, and Universitätsklinikum Schleswig-Holstein on numerous international projects. His expertise extends to training scientists, supervising research students, and contributing to impactful research. Additionally, he has served as Editor-in-Chief of the SJUOZ journal and actively participated in global microbiome conservancy initiatives. With a proven track record of research, teaching, and collaboration, Dr. Ibrahim is dedicated to advancing microbiome science and fostering academic excellence.

Research Interest

Dr. Khalid Subhi Ibrahim’s research interests focus on biomedical sciences, with expertise in diagnostic and molecular microbiology, clinical biochemistry, and bioinformatics. His work centers on understanding the role of gut microbiome changes in health and disease, particularly in obesity, Type 2 diabetes mellitus (T2DM), and pollution. Employing advanced molecular techniques and next-generation sequencing, he investigates microbiota in humans, animals, soils, and wastewater, emphasizing 16S rRNA analysis using tools like QIIME2 and PICRUSt2. Dr. Ibrahim’s research extends to metagenomics and functional analysis of microbiomes in various contexts, including colorectal cancer, nosocomial infections in children, and zoonotic diseases in livestock. His collaborations span globally, engaging with institutions such as MIT, Universitätsklinikum Schleswig-Holstein, and the University of Tartu. Driven by a passion for microbiome research, he aims to advance in silico analysis techniques, enriching the understanding of microbial ecosystems and their impacts on human and environmental health.

Award and Honor

Dr. Khalid Subhi Ibrahim, a distinguished microbiologist and academic, has earned recognition for his remarkable contributions to biomedical sciences, particularly in microbiome research. Serving as Assistant Professor at the University of Zakho, Dr. Ibrahim leads the Global Microbiome Conservancy in Iraq and holds the prestigious position of Editor-in-Chief for the Scientific Journal of University of Zakho (SJUOZ). His collaborative endeavors span globally, involving partnerships with renowned institutions such as MIT, Universitätsklinikum Schleswig-Holstein, and Monash University. Dr. Ibrahim’s accolades include delivering impactful presentations at international conferences and publishing high-impact research on gut microbiota’s role in obesity, Type 2 diabetes, and pollution. His expertise in bioinformatics and next-generation sequencing has advanced the understanding of microbial communities in diverse ecosystems. Committed to mentorship and innovation, Dr. Ibrahim’s career reflects a dedication to advancing scientific knowledge and fostering international collaboration in microbiome science.

Conclusion

Dr. Khalid Subhi Ibrahim is a distinguished researcher with expertise in diagnostic and molecular microbiology, clinical biochemistry, and microbiome analysis. His extensive academic and professional journey reflects a strong commitment to advancing biomedical sciences, with a particular focus on gut microbiome research in relation to obesity, Type 2 diabetes, pollution, and colorectal cancer. Dr. Ibrahim’s collaborative projects with esteemed institutions, including MIT and the University of Tartu, underscore his global impact and research network. His proficiency in cutting-edge techniques such as next-generation sequencing, bioinformatics, and microbiota analysis highlights his technical expertise. Additionally, his dedication to knowledge dissemination through teaching, supervising, and publishing further solidifies his contributions to science. While Dr. Ibrahim’s focus on microbiome studies is commendable, expanding his publication record in high-impact journals would further strengthen his academic influence. Overall, Dr. Khalid Subhi Ibrahim demonstrates exceptional merit as a candidate for the Best Researcher Award.

Publications Top Noted

  1. Title: Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
    Authors: Naghavi, M., Ong, K.L., Aali, A., Wool, E.E., Murray, C.J.L.
    Year: 2024
    Citations: 259
  2. Title: Retrospective analysis of pediatric sepsis and the burden of antimicrobial resistance in Duhok, Kurdistan Region of Iraq
    Authors: Ibrahim, D.R., Saadi, A.T., Yahya, N.B., Alarsalani, B.K., Ibrahim, K.S.
    Year: 2024
    Citations: 0
  3. Title: Global Burden of Cardiovascular Diseases and Risks, 1990-2022
    Authors: Mensah, G.A., Habtegiorgis Abate, Y., Abbasian, M., Murray, C.J.L., Roth, G.A.
    Year: 2023
    Citations: 295
  4. Title: Chinese medicine, Qijudihuang pill, mediates cholesterol metabolism and regulates gut microbiota in high-fat diet-fed mice, implications for age-related macular degeneration
    Authors: Cao, Y., Ibrahim, K.S., Li, X., Craft, J.A., Shu, X.
    Year: 2023
    Citations: 0
  5. Title: Molecular Characterization of Extended Spectrum β-Lactamase (ESBL) and Virulence Gene-Factors in Uropathogenic Escherichia coli (UPEC) in Children in Duhok City, Kurdistan Region, Iraq
    Authors: Hasan, S.M., Ibrahim, K.S.
    Year: 2022
    Citations: 5
  6. Title: In silico analysis of bacterial metabolism of glutamate and GABA in the gut in a rat model of obesity and type 2 diabetes
    Authors: Ibrahim, K.S., Bourwis, N., Dolan, S., Craft, J.A.
    Year: 2022
    Citations: 2
  7. Title: Effect of a TSPO ligand on retinal pigment epithelial cholesterol homeostasis in high-fat fed mice, implication for age-related macular degeneration
    Authors: Biswas, L., Ibrahim, K.S., Li, X., Craft, J., Shu, X.
    Year: 2021
    Citations: 16
  8. Title: Transcriptome-wide changes associated with the reproductive behaviour of male guppies exposed to 17α-ethinyl estradiol
    Authors: Saaristo, M., Craft, J.A., Tyagi, S., Ibrahim, K.S., Wong, B.B.M.
    Year: 2021
    Citations: 8
  9. Title: Prevalence and Hemato-biochemical Studies on Theileriosis in Naturally Infected Cattle in Erbil Province
    Authors: Aziz, K., Qader, N., Ibrahim, K.
    Year: 2021
    Citations: 3
  10. Title: Etifoxine reverses weight gain and alters the colonic bacterial community in a mouse model of obesity
    Authors: Ibrahim, K.S., Craft, J.A., Biswas, L., Spencer, J., Shu, X.
    Year: 2020
    Citations: 15

 

 

Yuanyuan Li | Genetics and Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Dr. Yuanyuan Li | Genetics and Molecular Biology | Best Researcher Award

Attending physician, Department of Endocrinology, Children’s Hospital of Nanjing Medical University, China.

Yuanyuan Li is a dedicated pediatrician and researcher with a Ph.D. in Clinical Medicine (Pediatrics) from Nanjing Medical University. Her research focuses on pediatric metabolic and kidney diseases, with particular interest in metabolic dysfunction-associated fatty liver disease. Li has published extensively as the first or corresponding author in prestigious journals, contributing valuable insights into liver disease, kidney dysfunction, and related metabolic conditions. She has led significant research projects funded by the National Natural Science Foundation of China and the China Postdoctoral Science Foundation. Her clinical expertise is recognized through awards such as the Best Resident Physician Award and the Ruihua First-Class Scholarship from Nanjing Children’s Hospital. Li’s research holds the potential for a positive impact on pediatric healthcare, while her leadership in both clinical and research settings highlights her as a rising scholar in her field.

Profile:

Education

Yuanyuan Li has a solid educational foundation in Clinical Medicine, specializing in Pediatrics. She earned her Ph.D. in Clinical Medicine (Pediatrics) from Nanjing Medical University in 2020, under the supervision of Professor Zhanjun Jia. Her doctoral research focused on pediatric diseases, with a particular emphasis on metabolic and kidney disorders. Prior to her Ph.D., Li completed her Master of Science in Clinical Medicine (Pediatrics) at the same university in 2017, guided by Professor Aihua Zhang. During this time, she honed her clinical and research skills, gaining in-depth knowledge of pediatric healthcare. Li began her academic journey with a Bachelor of Science in Clinical Medicine (Pediatrics), which she completed in 2015. Her comprehensive education, grounded in both theoretical knowledge and practical experience, has equipped her with the expertise to conduct impactful research and provide specialized pediatric care, particularly in the fields of metabolism and kidney disease.

Professional Experience

Yuanyuan Li has extensive professional experience as a pediatrician at Nanjing Children’s Hospital, where she has been serving since October 2020. In this role, she is responsible for the specialized diagnosis and treatment of pediatric diseases, with a particular focus on metabolic and kidney-related conditions. Her clinical expertise is complemented by her active involvement in epidemiological research, where she investigates the occurrence of pediatric diseases and explores related pathogenesis. Li’s dedication to integrating clinical practice with research allows her to translate scientific findings into improved patient care. Additionally, she has led several research projects funded by prestigious institutions such as the National Natural Science Foundation of China and the China Postdoctoral Science Foundation. Her role as a project head in these research initiatives reflects her leadership abilities and commitment to advancing knowledge in the field of pediatric health, particularly in metabolic disorders and kidney diseases.

Research Interests

Yuanyuan Li’s research interests focus on pediatric metabolic and kidney diseases, with a particular emphasis on understanding metabolic dysfunction and its implications. Her work explores the characteristics and pathogenesis of metabolic dysfunction-associated fatty liver disease, delving into the intricate mechanisms that connect metabolic disorders with liver damage. Additionally, she investigates kidney diseases, studying conditions like acute kidney injury and renal fibrosis, especially in pediatric populations. Yuanyuan is also interested in oxidative stress and its role in metabolic and infectious diseases, examining how factors like birthweight influence disease development. Her research aims to uncover the molecular pathways involved in these conditions, with the ultimate goal of improving diagnosis, treatment, and prevention strategies. By combining clinical and basic research, she contributes to a deeper understanding of metabolic diseases, hoping to make a significant impact on pediatric healthcare and public health outcomes.

Award and Recognition

Yuanyuan Li has received multiple prestigious awards and recognitions throughout her academic and professional career. She was honored with the Best Resident Physician Award at Nanjing Children’s Hospital in 2021, a testament to her outstanding clinical expertise and dedication to pediatric care. That same year, she earned the Ruihua First-Class Scholarship, further acknowledging her academic excellence and commitment to research. Yuanyuan has led several significant research projects, including those funded by the National Natural Science Foundation of China and the China Postdoctoral Science Foundation, highlighting her leadership and innovation in the field of metabolic and kidney diseases. Her numerous publications in high-impact journals solidify her reputation as an emerging leader in clinical and basic research. These accolades reflect not only her individual achievements but also her contribution to advancing pediatric medicine and metabolic disease research on a national and international level.

Conclusion

Yuanyuan Li’s academic achievements, research contributions, and clinical excellence position her as a strong contender for the Research for Best Scholar Award. Her focus on pediatric metabolic and kidney diseases addresses critical healthcare challenges, and her leadership in securing research funding demonstrates her potential for sustained scholarly impact. However, further development in international collaboration, mentorship, and research diversification could enhance her candidacy and future contributions to the academic community.

Publication Top Notes

    1. QbD-Based Stability-Indicating RP-HPLC Method Development and Validation for the Estimation of Favipiravir—An Eco-Friendly ApproachAuthors: Siri Chandana, M., Sujatha, K., Ajitha, A., Narendra, P., Sonia, K.

      Year: 2024

      Citation: Journal of AOAC International, 107(3), pp. 377–386. 🧪🌱

    2. An Overview of Pharmacological Activities and Beneficial Effects of 3-HydroxyflavoneAuthors: Ayyanna, C., Kuppusamy, S., Kumar, P.P.

      Year: 2024

      Citation: Macromolecular Symposia, 413(2), 2300078. 📚💊

    3. Analytical Quality by Design-Assisted HPLC Method for Quantification of Canagliflozin and Stability StudiesAuthors: Azhakesan, A., Kuppusamy, S.

      Year: 2023

      Citation: ACS Omega, 8(8), pp. 7407–7414. 🔍📈

    4. Development and Validation of UFLC-MS/MS Analytical Method for the Simultaneous Quantification of Antibiotic Residues in Surface Water, Groundwater, and Pharmaceutical Waste Water Samples from South IndiaAuthors: Kamatham, S., Seeralan, M., Sekar, U., Kuppusamy, S.

      Year: 2023

      Citation: ACS Omega. 🌊💧

    5. QbD-Based Development and Validation of Novel Stability-Indicating Method for the Assay and Dissolution of Garenoxacin in Garenoxacin TabletsAuthors: Azhakesan, A., Kuppusamy, S.

      Year: 2022

      Citation: Journal of AOAC International, 105(2), pp. 370–378. 📦💊

    6. Canagliflozin: A review with specific focus on analytical methods in biological matrices and pharmaceuticalsAuthors: Azhakesan, A., Kuppusamy, S.

      Year: 2022

      Citation: Reviews in Analytical Chemistry, 41(1), pp. 287–300. 🧬📖

    7. Formulation and Evaluation of Miglitol Matrix Tablets by Using Hibiscus Rosa Sinensis Leaves MucilageAuthors: Deepika, B., Sujatha, K., Thanga Thirupathi, A., Chamundeeswari, D.

      Year: 2021

      Citation: Research Journal of Pharmacy and Technology, 14(1), pp. 245–248. 🌺💊

    8. Bioanalytical Method Development and Validation for Simultaneous Estimation of Nitazoxanide and Ofloxacin in Human Plasma by RP-HPLCAuthors: Ajitha, A., Abbulu, K., Sujatha, K., Sireesha, P.

      Year: 2020

      Citation: Indian Drugs, 57(10), pp. 47–57. 💉🔬

    9. Bioanalytical Method Development and Validation of Garenoxacin Mesylate in Human Plasma by RP-HPLCAuthors: Ajitha, A., Sujatha, K., Abbulu, K.

      Year: 2019

      Citation: International Journal of Research in Pharmaceutical Sciences, 10(2), pp. 1314–1320. 🧪🩸

    10. The Identification of Bioactive Compounds from Turbinaria Ornata (Turner) J. Agaradh and Computational StudiesAuthors: Deepa, S., Sujatha, K., Velmurugan, D.

      Year: 2019

      Citation: Pharmacognosy Journal, 11(5), pp. 873–883. 🍃🔍

Paul Cullen | Genetics | Best Researcher Award

Posted on by ScienceFather

Dr. Paul Cullen | Genetics | Best Researcher Award

Doctorate at University at Buffalo, United States

Dr. Paul Cullen is a Professor in the Department of Biological Sciences at the University at Buffalo, specializing in molecular genetics and cell biology. He completed his postdoctoral training at the Institute of Molecular Biology at the University of Oregon, where he worked on MAP kinase (MAPK) signaling pathways, funded by grants from the American Heart Association and the National Institutes of Health (NIH). Dr. Cullen earned his Ph.D. in Molecular Genetics from Washington University in Saint Louis, where his research focused on bacterial nitrogen control proteins. He holds a Bachelor of Science in Biological Sciences from the University of Illinois at Urbana-Champaign, graduating Magna Cum Laude with Distinction. Dr. Cullen’s research interests revolve around understanding the regulation of cellular differentiation and signaling pathways, particularly in yeast. He has received numerous accolades, including the UB Exceptional Scholar’s Award and the Distinguished Postdoc Mentor Award. His work is supported by multiple NIH grants, and he has contributed significantly to the scientific community through publications and mentorship.

Profile

Education

Dr. Paul Cullen holds an impressive educational background in the field of biological sciences and molecular genetics. He earned his Bachelor of Science degree in Biological Sciences from the University of Illinois, Urbana-Champaign, graduating Magna Cum Laude with Distinction in 1990. His undergraduate thesis, titled “Effect of Ecdysone on In Vitro Pupal Wing Development in Lepidoptera,” was conducted under the supervision of Dr. Judith Willis and Dr. Johnathan Widom. Following this, Dr. Cullen pursued his Doctor of Philosophy (Ph.D.) in Molecular Genetics at Washington University, Saint Louis, completing his degree in 1997. His Ph.D. research, titled “Bacterial Nitrogen Control Proteins,” was guided by Dr. Robert G. Kranz. Additionally, from 1998 to 2004, Dr. Cullen completed postdoctoral training at the Institute of Molecular Biology at the University of Oregon, under the mentorship of Dr. George F. Sprague, Jr. His postdoctoral work was supported by prestigious grants from the American Heart Association and the National Institutes of Health (NIH), further solidifying his expertise in molecular biology.

Professional Experience

Dr. Paul Cullen has held a series of prestigious academic and research positions throughout his career. He is currently a Professor in the Department of Biological Sciences at the University at Buffalo, where he has been a faculty member since 2004. Prior to his promotion to Professor in 2017, Dr. Cullen served as an Associate Professor from 2010 to 2017 and as an Assistant Professor from 2004 to 2010. He has also held a joint appointment as Clinical Research Assistant Professor in the Department of Microbiology and Immunology since 2005. Earlier in his career, Dr. Cullen was a Senior Research Fellow at the Institute of Molecular Biology at the University of Oregon from 2000 to 2004. He has also contributed to scientific review panels, including serving as an NIH Review Panelist for Eukaryotic Pathogens in 2024. In addition to his research, Dr. Cullen has been deeply involved in academic administration, serving as the Director of Graduate Affairs for the Department of Biological Sciences from 2019 to 2024 and as a member of the Graduate School Executive Committee from 2023 to 2024.

Research Interest

Dr. Paul Cullen’s research interests focus on understanding the molecular mechanisms that regulate cellular differentiation, particularly through MAP kinase (MAPK) signaling pathways. His work explores how these pathways control cellular responses to environmental cues, with a special emphasis on the filamentous growth of Saccharomyces cerevisiae (yeast). Dr. Cullen investigates the role of cell polarity proteins in modulating MAPK signaling and how regulatory proteins influence these pathways. His research also extends to studying signal transduction in various biological systems, aiming to uncover broader implications for cellular behavior and development in eukaryotic organisms. Through his work, Dr. Cullen seeks to advance knowledge of genetic and molecular processes that underpin complex biological responses, contributing to the fields of molecular genetics, cell biology, and microbiology.

Research Skills

Dr. Paul Cullen possesses extensive research skills in molecular genetics and cell biology, particularly in the regulation of MAP kinase (MAPK) signaling pathways. His expertise includes advanced molecular techniques such as gene manipulation, protein-protein interaction studies, and genetic screening in model organisms like Saccharomyces cerevisiae. Dr. Cullen is skilled in using molecular and genetic tools to investigate cellular differentiation, signal transduction, and environmental response mechanisms. He has a strong background in high-throughput screening, microscopy, and quantitative data analysis. His research also involves cutting-edge technologies in genetic sequencing, bioinformatics, and structural biology, contributing to his deep understanding of cellular signaling networks and their implications for health and disease.

Award and Recognition

Dr. Paul Cullen has received numerous accolades for his exemplary contributions to research and education. In 2023, he was honored with the UB Exceptional Scholar’s Award for Sustained Achievement and the UB Graduate School Distinguished Postdoc Mentor Award, recognizing his significant impact in mentorship. Additionally, he received the Milton Plesur Excellence in Teaching Award in 2008 for his dedication to student learning. His active membership in professional organizations such as the American Society of Cell Biology and the American Society of Microbiology further highlights his commitment to advancing the field of molecular biology.

Conclusion

Dr. Paul Cullen’s remarkable achievements in molecular biology, sustained research contributions, and commitment to mentoring make him a distinguished figure in his field. His combination of academic excellence, leadership, and impactful research positions him as an exemplary candidate for the “Research for Best Researcher Award.”

Publication Top Notes

  • “Glucose depletion causes haploid invasive growth in yeast”
    • Journal: Proceedings of the National Academy of Sciences
    • Cited by: 444
    • Year: 2000
    • Volume: 97, Issue 25
    • Pages: 13619-13624
  • “The regulation of filamentous growth in yeast”
    • Journal: Genetics
    • Cited by: 348
    • Year: 2012
    • Volume: 190, Issue 1
    • Pages: 23-49
  • “A signaling mucin at the head of the Cdc42-and MAPK-dependent filamentous growth pathway in yeast”
    • Journal: Genes & Development
    • Cited by: 268
    • Year: 2004
    • Volume: 18, Issue 14
    • Pages: 1695-1708
  • “GTPase-activating proteins for Cdc42”
    • Journal: Eukaryotic Cell
    • Cited by: 170
    • Year: 2002
    • Volume: 1, Issue 3
    • Pages: 469-480
  • “Defects in Protein Glycosylation Cause SHO1-Dependent Activation of a STE12 Signaling Pathway in Yeast”
    • Journal: Genetics
    • Cited by: 147
    • Year: 2000
    • Volume: 155, Issue 3
    • Pages: 1005-1018
  • “Cleavage of the signaling mucin Msb2 by the aspartyl protease Yps1 is required for MAPK activation in yeast”
    • Journal: The Journal of Cell Biology
    • Cited by: 144
    • Year: 2008
    • Volume: 181, Issue 7
    • Pages: 1073-1081
  • “Secreted aspartic protease cleavage of Candida albicans Msb2 activates Cek1 MAPK signaling affecting biofilm formation and oropharyngeal candidiasis”
    • Journal: PLoS One
    • Cited by: 112
    • Year: 2012
    • Volume: 7, Issue 11
    • Pages: e46020
  • “Candida albicans biofilm development is governed by cooperative attachment and adhesion maintenance proteins”
    • Journal: NPJ Biofilms and Microbiomes
    • Cited by: 111
    • Year: 2019
    • Volume: 5, Issue 1
    • Pages: 21

Anam | Genetics and Molecular Biology | Best Scholar Award

Posted on by ScienceFather

Mrs. Anam | Genetics and Molecular Biology | Best Scholar Award

P.hD Biochemistry research scholar  of University of lucknow,lucknow and ICAR-Indian institute of sugarcane research,lucknow, India .

Mrs. Anam is a dedicated researcher with expertise in biotechnology and biochemistry. She holds a Master’s degree in Biotechnology and Chemistry and is currently pursuing a Ph.D. in Biochemistry at the University of Lucknow, India. Mrs. Anam’s research interests encompass molecular biology, biochemical pathways, and biotechnological applications, with a focus on advancing scientific knowledge in these areas. She has valuable professional experience as a Young Professional-1 in the Plant Physiology and Biochemistry Division at ICAR-Indian Institute of Sugarcane Research, where she contributes to cutting-edge research projects. Mrs. Anam’s skills include experimental design, molecular biology techniques, biochemical assays, and data analysis. She is passionate about scientific inquiry, evidenced by her participation in research training programs and academic pursuits. Mrs. Anam’s dedication to research and her multidisciplinary skill set position her as a promising researcher in the field of biotechnology and biochemistry.

Professional Profiles:

Education

Mrs. Anam has attained notable educational qualifications in biotechnology and chemistry, underscoring her commitment to academic excellence and expertise in scientific disciplines. She completed a Master of Science (M.Sc) in Biotechnology, focusing on advanced molecular biology, genetics, and biotechnological applications. This postgraduate degree equips her with specialized knowledge essential for research and development in the biotechnology sector. Additionally, Mrs. Anam holds Bachelor of Science (B.Sc) degrees in Biotechnology and Chemistry, providing a strong foundation in biological sciences and chemical principles. This interdisciplinary educational background enhances her understanding of biochemical processes and their practical applications. Mrs. Anam’s academic achievements reflect her dedication to acquiring comprehensive skills and knowledge necessary for success in biotechnology, research, and laboratory work.

Professional Experience

Mrs. Anam possesses a wealth of professional experience in the dynamic field of biotechnology and biochemistry. Currently pursuing a Ph.D. in Biochemistry at the University of Lucknow, she is actively engaged in advanced research focusing on biochemical processes and their applications in biological systems. As a Young Professional-1 in the Plant Physiology and Biochemistry Division at ICAR-Indian Institute of Sugarcane Research, Lucknow, Mrs. Anam contributes to cutting-edge research projects in plant physiology, biochemistry, and agricultural biotechnology. Her role involves hands-on experimentation and analysis, further enhancing her expertise in applied biotechnological research. Previously, she was selected as a BCIL Trainee through the Biotechnology Industry Training Programme (BITP) by the Department of Biotechnology (DBT), Government of India, and completed a specialized industrial training program at AquaBiochip Genomics India Pvt. Ltd., Biotech Park, Lucknow. These experiences underscore Mrs. Anam’s proficiency in scientific research, laboratory techniques, and industry-relevant applications within the biotechnology field. Her diverse professional journey reflects a strong commitment to advancing knowledge and innovation in biotechnology and biochemistry.

Research Interest

Mrs. Anam’s research interests are diverse and encompass key areas of biotechnology and biochemistry. She is particularly focused on molecular biology, investigating gene expression and cellular processes. Additionally, Mrs. Anam is interested in exploring biochemical pathways and their impact on metabolism and cellular regulation. She is keen on biotechnological applications, aiming to develop innovative solutions for agriculture, healthcare, and environmental sustainability. Her passion extends to immunology and infectious diseases, with a focus on host-pathogen interactions and immune system modulation. In her current role in plant physiology research, Mrs. Anam seeks to understand plant biochemistry to enhance crop productivity and resilience. Through her multidisciplinary approach, she aims to contribute to scientific advancements that address critical societal and environmental challenges.

Award and Honors

Mrs. Anam has been recognized for her academic achievements and dedication to scientific inquiry in biotechnology and biochemistry. Her selection as a BCIL Trainee through the Biotechnology Industry Training Programme (BITP) by the Department of Biotechnology (DBT), Government of India, signifies her academic excellence and potential in biotechnological applications. As a Ph.D. researcher in Biochemistry at the University of Lucknow, Mrs. Anam demonstrates a strong commitment to advanced research and scholarly pursuits. While specific awards and honors may vary, these achievements highlight her academic merit and contributions to the field. Mrs. Anam’s pursuit of excellence in biotechnology and biochemistry positions her as a promising researcher with the potential for further recognition and impactful contributions to the scientific community.

Research Skills

Mrs. Anam possesses a diverse and comprehensive skill set in research methodologies essential for biotechnology and biochemistry. She excels in experimental design, molecular biology techniques (DNA isolation, PCR), biochemical assays (enzyme kinetics, protein analysis), and cell culture. Mrs. Anam is adept at data analysis using statistical tools and bioinformatics software to derive meaningful insights from experimental data. She demonstrates strong scientific writing skills for manuscript preparation and grant proposals, supported by her ability to conduct thorough literature reviews. Proficient in operating laboratory instrumentation and managing research projects, Mrs. Anam exhibits a well-rounded approach to scientific inquiry. Her expertise equips her to contribute significantly to advancing knowledge and innovation in biotechnology, biochemistry, and related fields. Mrs. Anam’s research skills underscore her potential for impactful contributions to scientific research and development endeavors.